Regional UK TTP registry: correlation with laboratory ADAMTS 13 analysis and clinical features.
about
Contemporary clinical management of the cerebral complications of preeclampsiaAcquired idiopathic ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in a population from JapanRefractory thrombotic thrombocytopenic purpura associated with oral contraceptives and factor V Leiden: a case report[Thrombotic-thrombocytopenic purpura].Clinical features of severe acquired ADAMTS13 deficiency in thrombotic thrombocytopenic purpura: the Korean TTP registry experience.Human immunodeficiency virus associated thrombotic thrombocytopenic purpura--favourable outcome with plasma exchange and prompt initiation of highly active antiretroviral therapy.Idiopathic noncirrhotic intrahepatic portal hypertension is associated with sustained ADAMTS13 Deficiency.Residual plasmatic activity of ADAMTS13 is correlated with phenotype severity in congenital thrombotic thrombocytopenic purpura.Diagnosis and management of maternal thrombocytopenia in pregnancy.Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies.ADAMTS-13 activity and autoantibodies classes and subclasses as prognostic predictors in acquired thrombotic thrombocytopenic purpura.Preventing maternal deaths due to acquired thrombotic thrombocytopenic purpura.Coma in thrombotic thrombocytopenic purpura.Multiple in silico tools predict phenotypic manifestations in congenital thrombotic thrombocytopenic purpura.Management and outcomes for patients with TTP: analysis of 100 cases at a single institution.High prevalence of infectious events in thrombotic thrombocytopenic purpura and genetic relationship with toll-like receptor 9 polymorphisms: experience of the French Thrombotic Microangiopathies Reference Center.Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).Measurement and prevalence of circulating ADAMTS13-specific immune complexes in autoimmune thrombotic thrombocytopenic purpura.How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndromeAcute pancreatitis induced thrombotic thrombocytopenic purpura.Safety and efficacy of cryoprecipitate-poor plasma as a replacement fluid for therapeutic plasma exchange in thrombotic thrombocytopenic purpura: a single center retrospective evaluation.Non-secreting benign glucagonoma diagnosed incidentally in a patient with refractory thrombocytopenic thrombotic purpura: report of a case.ADAMTS-13 in the Diagnosis and Management of Thrombotic Microangiopathies.A phase-II sequential case-series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory thrombotic thrombocytopenic purpura treated with rituximab.A proposal: the need for thrombotic thrombocytopenic purpura Specialist Centres--providing better outcomes.Diagnosis and management of thrombotic thrombocytopenic purpura (TTP) in Australia: findings from the first 5 years of the Australian TTP/thrombotic microangiopathy registry.The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathiesHigh prevalence of hereditary thrombotic thrombocytopenic purpura in central Norway: from clinical observation to evidence.Twice-daily therapeutical plasma exchange-based salvage therapy in severe autoimmune thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.How we manage thrombotic microangiopathies in pregnancy.Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs).Correlation between ADAMTS13 activity and neurological impairment in acute thrombotic microangiopathy patients.Systemic Lupus Erythematosus Presenting as Refractory Thrombotic Thrombocytopenic Purpura: A Diagnostic and Management Challenge. A Case Report and Concise Review of the LiteratureDiagnosis and management of acquired thrombotic thrombocytopenic purpura in southeast China: a single center experience of 60 cases.Adenocarcinoma of the lung presenting as thrombotic thrombocytopenic purpura.Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) 2017 in Japan.Detection of Plasma Protease Activity Using Microsphere-Cytometry Assays with E. coli Derived Substrates: VWF Proteolysis by ADAMTS13Thrombotic Thrombocytopenic Purpura in Black People: Impact of Ethnicity on Survival and Genetic Risk FactorsGeneration of Anti-Murine ADAMTS13 Antibodies and Their Application in a Mouse Model for Acquired Thrombotic Thrombocytopenic Purpura.Management of thrombotic thrombocytopenic purpura: current perspectives
P2860
Q21128665-6DCC744D-D8D5-46B5-8788-AF57D36223F7Q28731380-BBDD41AE-9FF6-4E6B-B006-B5920D23D258Q33386640-76B4947B-8938-427A-8F89-A9E16A0F40A7Q33391233-A24B7097-CF10-4E9A-AE7F-C28A8383885FQ33393950-ABEFD729-9F41-4EB3-A7F4-142BBFCB589DQ33394441-A47DCE70-7737-42FC-8D3E-559AB0F60720Q33395323-D7730994-42FD-4C2E-8608-F390184F5178Q33400891-C378B6E9-9516-454F-9320-9D7CB1F2DD0DQ33401045-34F0EE6D-DAFD-4D69-BB99-1FA8FDE50555Q33401403-B3FDD7A2-1180-48D0-955C-25B850D84BE9Q33401647-A6B2C5FF-439F-45F5-95B3-EA9DF67E8BC3Q33401773-140A3A40-DDAB-4FCC-8608-6B76AFED561BQ33402345-1BF6A1C8-D5F5-4817-87D7-E8197D36C32BQ33405479-BD6CAF43-3683-4F29-8AA6-212F4D729958Q33407187-4477F122-9716-484F-BA9A-6D5EA9964BE8Q33407984-1C95F88E-2272-4DEC-B132-17618FCD4322Q33410829-09C2AC9F-DD50-4601-9AAE-8C1B793F002AQ33412212-4439B5BD-31AF-4B3C-800F-4EF6CBA2585FQ33412445-67DD9369-D238-4AC2-A0B6-E0C8EF9F1A47Q33414293-37F31E20-DEAA-4937-BC5E-9AB63B9B555BQ33415693-90B2DF3F-3A3D-4FDD-B74E-3896671AF2BBQ33418557-27C427EB-0854-42E7-B882-DC0E518D9CDEQ33418645-D01C8D45-7142-4CC8-8B41-CAC0001B775CQ33421822-AAC2567D-5ED6-41E9-9C0B-2CAAEBD58B93Q33423846-D5AFEAB5-8BD9-450C-8090-72E1952E843FQ33426823-6DB04A13-76E2-4459-99BB-1FB8AE73EDD8Q33427495-04923D5C-DCD9-428A-A67B-8D322D288C29Q33427539-C901779D-B7B8-4504-ABC2-576029DEA529Q33427885-472F6E42-0823-4B58-8160-204157DC8918Q33431084-E7132902-8BCA-44D1-BEE1-316610BB72ACQ33431806-B54BD46A-0628-43EE-A81B-FBAC1F435CC3Q33433636-49A613C5-4EEC-4BE1-8FC9-FAF9FCD47318Q33436271-8DD3B490-1867-47F3-B9A0-6A9D8E19F9DDQ33437015-37804448-C062-4A86-A602-A89AC8883753Q33441077-FEAE8A1D-9739-477F-8F6D-9ED25E75448BQ33442170-0628BF0F-A8C7-4499-9592-9F454A722A69Q35636250-3D6F7535-8D28-480F-82A0-A00AD58AE4F4Q36068855-03414850-6ADD-49FC-877A-69AA860BE2E0Q36091783-D7536FD0-A8EC-4AAF-830F-94A6F1094675Q37577785-BCD08D55-288F-4689-8DF8-C8940123CE09
P2860
Regional UK TTP registry: correlation with laboratory ADAMTS 13 analysis and clinical features.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Regional UK TTP registry: corr ...... nalysis and clinical features.
@ast
Regional UK TTP registry: corr ...... nalysis and clinical features.
@en
type
label
Regional UK TTP registry: corr ...... nalysis and clinical features.
@ast
Regional UK TTP registry: corr ...... nalysis and clinical features.
@en
prefLabel
Regional UK TTP registry: corr ...... nalysis and clinical features.
@ast
Regional UK TTP registry: corr ...... nalysis and clinical features.
@en
P2093
P1476
Regional UK TTP registry: corr ...... nalysis and clinical features.
@en
P2093
Beverley Hunt
David Bevan
Helen Yarranton
Ian Mackie
Jamie Cavenagh
Marie Scully
Ri Liesner
Samuel Machin
Sylvia Benjamin
P304
P356
10.1111/J.1365-2141.2008.07276.X
P407
P577
2008-07-08T00:00:00Z